Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 11 of 11

List	Outcome	Time frame	Description
Primary	Change from baseline in albuminuria after 4 weeks combined zibotentan and dapagliflozin treatment versus four weeks treatment with zibotentan alone.	The albuminuria will be measured before start of medication intake and after the last intake of medication for each treatment period. This concerns a 4 week time frame.	The change in albuminuria as expressed the percentage change of the log-transformed albumin:creatinine ratio in mg/gram. The log-transformation is because of the skewed distribution.
Secondary	Change in Extracellular Fluid	4 weeks	Extracellular Fluid measured by bioimpedance spectroscopy
Secondary	Change in bodyweight	4 weeks	Change in kilograms
Secondary	Change in NT-proBNP	4 weeks	N-terminal B-type natriuretic peptide (NT-proBNP)
Secondary	Change in BNP	4 weeks	B-type natriuretic peptide (BNP)
Secondary	Change in Glomerular Filtration Rate (GFR)	4 weeks	Glomerular Filtration Rate (GFR) using iohexol clearance techniques.
Secondary	Change in Extracellular volume (ECV)	4 weeks	Extracellular volume (ECV) using iohexol clearance techniques.
Secondary	Change in hematocrit	4 weeks	The percentage of red blood cells in blood
Secondary	Change in systolic and diastolic blood pressure	4 weeks	Change in blood pressure as measure in mmHg
Other	Change in renin-angiotensin-aldosterone system (RAAS) markers	4 weeks	Change in RAAS markers in plasma and urine
Other	Change in copeptin	4 weeks	Change in copeptin as a surrogate of vasopressin

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05570305/registered